GAMMA Investing’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$606K Buy
5,493
+1,006
+22% +$97.2K 0.02% 608
2026
Q2
$351K Buy
4,487
+542
+14% +$37K 0.01% 859
2026
Q1
$255K Sell
3,945
-79
-2% -$5.57K 0.01% 949
2025
Q4
$271K Buy
4,024
+266
+7% +$17.9K 0.01% 834
2025
Q3
$276K Buy
3,758
+943
+33% +$62.6K 0.02% 772
2025
Q2
$146K Buy
2,815
+13
+0.5% +$740 0.01% 1133
2025
Q1
$179K Buy
2,802
+1,865
+199% +$108K 0.01% 823
2024
Q4
$44.8K Buy
937
+70
+8% +$3.59K ﹤0.01% 1741
2024
Q3
$49.6K Buy
867
+350
+68% +$20.1K ﹤0.01% 1504
2024
Q2
$27.1K Buy
517
+254
+97% +$11.1K ﹤0.01% 1654
2024
Q1
$10.7K Buy
263
+75
+40% +$2.81K ﹤0.01% 2023
2023
Q4
$6.36K Buy
+188
New +$7.08K ﹤0.01% 2123

Other funds holding HALO

GAMMA Investing's HALO Position: Q3 2026 in Review

GAMMA Investing increased its Halozyme (HALO) stake by 22% in Q3 2026, buying an estimated $97.2K and bringing the position to 5,493 shares worth $606K. The position accounts for 0.02% of the portfolio, ranked #608.

GAMMA Investing first reported a position in HALO in Q4 2023 and has held it in 12 quarters since. 31 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • GAMMA Investing held 5,493 shares of Halozyme worth $606K as of Q3 2026.
  • GAMMA Investing bought 1,006 Halozyme shares in Q3 2026, an estimated $97.2K.
  • Halozyme made up 0.02% of GAMMA Investing's portfolio in Q3 2026, its #608 holding.
  • GAMMA Investing first reported a position in Halozyme in Q4 2023 and has held it in 12 quarters since.
  • 31 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.